HCPCS code Q5124 — Inj. byooviz, 0.1 mg. Status: Active. Effective Jan 1, 2023. Source: CMS HCPCS Level II.

Q5124

Active

Inj. byooviz, 0.1 mg

Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jan 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9017

MUE — Medically Unlikely Edits

Maximum units of Q5124 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 10
Practitioner Services 10

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
64406-0019-01 Byooviz

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q1
    Inj. byooviz, 0.1 mg